H.R. 10857 · 119th Congress

To amend the Federal Food, Drug, and Cosmetic Act and Public Health Service Act to advance the next-generation of clinical development of novel treatments and cures, and for other purposes.

Stage
In committee
Sponsor
Jake Auchincloss
Introduced
2026-10-22
Latest action
2026-10-22 · Introduced in House

Action history

  1. 2026-10-22Introduced in House
  2. 2026-10-22Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  3. 2026-10-22Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.